谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract OT-36-01: Phase III study of GDC-0077 or placebo (pbo) with palbociclib (P) + fulvestrant (F) in patients withPIK3CA-mutant/hormone receptor-positive/HER2-negative locally advanced or metastatic breast cancer (HR+/HER2- LA/MBC)

Nicolas Turner,Komal Jhaveri,Kevin Kalinsky,Sibylle Loibl,Sherene Loi,Seock-Ah Im,Cristina Saura,Peter Schmid,Jennifer L Schutzman,Thomas J Stout,Guiyuan Lei,Katherine E Hutchinson,Eirini Thanopoulou,Dejan Juric

Ongoing Clinical Trials Abstracts（2021）

引用 0|浏览5
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要